BioAtla (BCAB) announced data in a poster titled, “Phase 2 Trial of Ozuriftamab Vedotin, a Conditionally Binding CAB-ROR2-ADC, in Patients with ...

Diakonos Oncology Corp., a clinical-stage biotechnology company developing a new generation of immunotherapies to treat challenging and aggressive cancers, today announced promising results from its ...

Twenty-eight students in the Jacobs School of Medicine and Biomedical Sciences were honored for outstanding achievements during the University at Buffalo’s 2025 Celebration of Student Academic ...

Medulloblastoma is a malignant brain tumor, most commonly found in children, that originates in the cerebellum. It's the most ...

Diagens has developed the Rapid AI karyotype total solution based on iMedImage ®, a globally leading general medical imaging ...

While you might not be able to catch Jurassic World: Rebirth in IMAX, 2025 still looks like it will be a banner year for ...

Harshvardhan Rane and Sonam Bajwa are collaborating for a musical love story, Ek Deewane Ki Deewaniyat. Directed by Milap ...

Discover how AI in healthcare is quietly revolutionizing the field—from diagnostics to drug discovery—enhancing care, reducing errors, and empowering clinicians.

Kajol returns to the big screen with Maa, a mythological horror film directed by Vishal Furia. Featuring a stellar cast ...

The singer canceled his summer tour dates and revealed he has a brain condition called normal pressure hydrocephalus. It's ...

A big setback for Reds prospect Rhett Lowder during his rehab assignment could put the starting pitcher out for an even ...

Five-year follow-up data from the Phase 3 ARCHES trial shows XTANDI (enzalutamide) plus androgen deprivation therapy (ADT) reduces risk of death by 30% After a median follow-up of 61.4 months, ...